Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma

Background: Immunotherapy has drastically changed the outlook for melanoma patients over the past decade. Specifically, the dual blockade of immune checkpoints using ipilimumab and nivolumab has shown unprecedented response rates and survival outcomes. This immense achievement, though, is at the cos...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Asher, Nethanel, Ben-Betzalel, Guy, Lev-Ari, Shaked, Shapira-Frommer, Ronnie, Steinberg-Silman, Yael, Gochman, Neta, Schachter, Jacob, Meirson, Tomer, Markel, Gal
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464656/
https://ncbi.nlm.nih.gov/pubmed/32824780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082329
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller